Diansong Zhou

27PUBLICATIONS
80CO-AUTHORS
PharmacogenomicsCancer therapy (excl. chemotherapy and radiation therapy)Economic models and forecastingStatistical and quantitative geneticsPharmaceutical delivery technologies
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (27)

|Sep 28, 2026
Population Pharmacokinetics and Exposure-response Analysis of Durvalumab in Patients with Limited-stage Small-cell Lung Cancer in the Phase 3 ADRIATIC Study.

|Sep 14, 2026
Exposure-Response Analyses of Datopotamab Deruxtecan (Dato-DXd), a TROP2-Directed Antibody-Drug Conjugate, in Advanced Non-small Cell Lung Cancer.

|Aug 12, 2026
PBPK Modeling of Esomeprazole to Support Adolescent Pharmacokinetic Extrapolation and Label Extension in Chinese Patients With Gastroesophageal Reflux Disease (GERD).

|Apr 14, 2026
Is a Clinical Trial With a Non-Bioequivalent Batch Necessary? The Critical Role of Intrasubject Variability in Olaparib Formulation Bridging by PBPK.

Jin Dong, Andrea Moir, Xavier Pepin

|Feb 15, 2026
Optimal Dosage Justification for Datopotamab Deruxtecan in HR-Positive/HER2-Negative Breast Cancer Through Model-Informed Drug Development Approaches.

Zoey Tang, KyoungSoo Lim, Yu Jiang

|Feb 04, 2026
Stochastic Gates for Covariate Selection in Population Pharmacokinetics Modeling.

Marija Kekic, Oleg Stepanov, Wenjuan Wang

Pageof 5

Frequent Collaborators

5 joint publications

Weifeng Tang

4 joint publications

Jin Dong

3 joint publications

Sharma Pradeep

2 joint publications

Marie Cullberg